Lipopolymer mediated siRNA delivery targeting aberrant oncogenes for effective therapy of myeloid leukemia in preclinical animal models脂质聚合物介导的靶向异常癌基因的siRNA递送在临床前动物模型中有效治疗髓系白血病JOURNAL OF CONTROLLED RELEASEIF11.52024-03-014PRE
TRAIL therapy and prospective developments for cancer treatmentJOURNAL OF CONTROLLED RELEASEIF11.52020-10-0151PREAI
Nucleic acid combinations: A new frontier for cancer treatmentJOURNAL OF CONTROLLED RELEASEIF11.52017-06-0121PREAI
Effects of pre-exposure to siRNA on silencing response: Do cells become resistant to siRNA silencing?CLINICAL CANCER RESEARCHIF10.22015-02-130PRE
Investigating siRNA delivery to chronic myeloid leukemia K562 cells with lipophilic polymers for therapeutic BCR-ABL down-regulationJOURNAL OF CONTROLLED RELEASEIF11.52013-12-0155PRE
Effective response of doxorubicin-sensitive and -resistant breast cancer cells to combinational siRNA therapyJOURNAL OF CONTROLLED RELEASEIF11.52013-11-0154PRE